Engineered immune cells take on autoimmune diseases in first human trial
NCT ID NCT07085104
First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 1 time
Summary
This early-stage study tests a new treatment called ALLO-329 for people with lupus, myositis, or scleroderma. The therapy uses specially engineered immune cells from a donor to target and calm the overactive immune system. The main goals are to check safety and see if it can improve disease symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC INFLAMMATORY MYOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Astera Cancer Care
RECRUITINGEast Brunswick, New Jersey, 08816, United States
Contact
-
Duke University Medical Center
RECRUITINGDurham, North Carolina, 27710, United States
Contact
-
Hôpital Maisonneuve Rosemont
RECRUITINGMontreal, Quebec, H1T 2M4, Canada
Contact
-
Icahn School of Medicine at Mount Sinai
RECRUITINGNew York, New York, 10029, United States
Contact
-
LDS Hospital - lntermountain Health
RECRUITINGSalt Lake City, Utah, 84143, United States
Contact
-
Loma Linda University Medical Center
RECRUITINGLoma Linda, California, 92354, United States
Contact
-
Mayo Clinic
RECRUITINGPhoenix, Arizona, 85054, United States
Contact
-
Mayo Clinic
RECRUITINGJacksonville, Florida, 32224, United States
Contact
-
Medical University of South Carolina
RECRUITINGCharleston, South Carolina, 29605, United States
Contact
-
Norton Cancer Institute, St. Matthews Campus
RECRUITINGLouisville, Kentucky, 40207, United States
Contact
-
Prisma Health
RECRUITINGGreenville, South Carolina, 29425, United States
Contact
-
The University of Chicago Medical Center
RECRUITINGChicago, Illinois, 60637, United States
Contact
-
University of Colorado Denver
RECRUITINGAurora, Colorado, 80045, United States
Contact
-
University of Iowa
RECRUITINGIowa City, Iowa, 52242, United States
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood particles may reveal hidden clues to scleroderma complications
- Engineered immune cells take aim at Hard-to-Treat muscle disease
- Could a simple injection dissolve painful calcium lumps in rare diseases?
- Finger injections aim to loosen stiff hands in scleroderma
- Continued anifrolumab treatment studied for lupus and related diseases
- Blood thinner may stop autoimmune disease before it starts